Company intelligence
SpeeDx Pty Ltd
Empowering clinicians to make informed treatment decisions.
About SpeeDx Pty Ltd
Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease.
Verified activity
Signals from SpeeDx Pty Ltd
5 published signals
Products & Services
SpeeDx Pty Ltd announced that RespiV PlexPlus is available only for research use and not for diagnostic procedures.
Reported by SpeeDx Pty Ltd
Research & Knowledge
SpeeDx Pty Ltd published a white paper about the importance of differentiating human rhinovirus and enterovirus in molecular diagnostics.
Reported by SpeeDx Pty Ltd
Research & Knowledge
SpeeDx Pty Ltd reported that RespiV PlexPlus detected 14 additional influenza A positive samples compared to BioFire.
Reported by SpeeDx Pty Ltd